Neoadjuvant chemotherapy followed by radical vaginal trachelectomy and adjuvant chemotherapy for clear cell cancer of the cervix a feasible approach and review

International Journal of Gynecological Cancer

Volumn 21, Issue 1, 2011, Pages 137-140

  Singh, Piksi ^a   Nicklin, James ^a   Hassall, Timothy ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Abdominal radical trachelectomy; Clear cell adenocarcinoma of the cervix; Neoadjuvant chemotherapy; Squamous cell carcinoma; Vaginal radical trachelectomy

Indexed keywords

CARBOPLATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CLEAR CELL ADENOCARCINOMA OF THE CERVIX; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MENARCHE; MENSTRUAL CYCLE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; PELVIS RADIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RADICAL VAGINAL TRACHELECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CERVIX UTERI; CHEMOTHERAPY, ADJUVANT; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOADJUVANT THERAPY; PACLITAXEL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 79951485664     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182011236     Document Type: Article

References (18)

1. Tavassoli FA, Deville P. WHO Classification Tumors of the Breast and Female Genital Organs, Volume 6. Lyon, France: IARC Press; 2003.
2. Hanselaar A, van Loosbroek M, Schuurbiers O, et al. Clear cell adenocarcinoma of vagina and cervix. An update of central Netherlands registry showing twin age incidence peaks. Cancer. 1997;79:2229-2236. (Pubitemid 27227389)
3. Boyd J, Takahashi H, Waggoner SE, et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer. 1996;77:505-513.
4. Reich O, Tamussino K, Lahousen M, et al. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol. 2000;76:331-335. (Pubitemid 30131503)
5. Thomas MB, Wright JD, Leiser AL, et al. Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecol Oncol. 2008;109:335-339.
6. Plante M, Lau S, Brydon L, et al. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report. Gynecol Oncol. 2006;101: 367-370.
7. McNall RY, Nowicki PD, Miller B, et al. Adenocarcinoma of the cervix and vagina in pediatric patients. Pediatr Blood Cancer. 2004;43:289-294. (Pubitemid 39025314)
8. Gien LT, Covens A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol. 2010;117:350-357.
9. Maneo A, Landoni F, Caspani G, et al. Chemotherapy and conization for preserving fertility in stage IB1 cervical cancer. 2004 Proceedings International Gynecologic Cancer Society. Int J Gynecol Cancer. 2004;14(suppl 1):694.
10. Robova H, Pluta M, Hrehorcak M, et al. High-dose density chemotherapy followed by simple trachelectomy: full-term pregnancy. Int J Gynecol Cancer. 2008;18: 1367-1371.
11. Abu-Rustum NR, Neubauer N, Sonoda Y, et al. Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecol Oncol. 2008;111:261-264.
12. Plante M, Renaud MC, Francois H, et al. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol. 2004;94:614-623. (Pubitemid 39194451)
13. Abu-Rustum NR, Su W, Levine DA, et al. Pediatric radical abdominal trachelectomy for cervical clear cell carcinoma: a novel surgical approach. Gynecol Oncol. 2005;97: 296-300. (Pubitemid 40403718)
14. Zanetta G, Fei F, Mangioni C. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Semin Oncol. 2000;27:23-27. (Pubitemid 30108672)
15. Mori T, Hosokawa K, Kinoshita Y, et al. Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Int J Gynecol Cancer. 2008;18:85-89.
16. Tinker AV, Bhagat K, Swenerton KD, et al. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience. Gynecol Oncol. 2005;98:54-58. (Pubitemid 40826418)
17. Sovak MA, Dupont J, Hensley ML, et al. Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study. Int J Gynecol Cancer. 2007;17:197-203. (Pubitemid 46213991)
18. Hertel H, Kohler C, Grund D, et al. Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol. 2006;103:506-511. (Pubitemid 44604493)